Apologies if this has been posted.In a historic first,...

Apologies if this has been posted.

In a historic first, Australians living with a rare form of epilepsy will have access to a medicinal cannabis drug, which is being listed on Australia’s Pharmaceutical Benefits Scheme (PBS) for the first time.From 1 May 2021, Australians living with Dravet syndrome, will have access to Epidyolex® (cannabidiol), a new treatment used in combination with at least two other anti-epileptic medicines on the PBS